Company: LRHC
Filing Date: 2025-08-20
Form Type: S-1/A
Source: 0001213900-25-078966
Chunk: 25

Company: La Rosa Holdings Corp.
Filing Date: 2025-08-20
Form: S-1/A
Chunk 25
---
, but not the obligation, to sell to the Selling Stockholder under the Facility, and that we comply with the other conditions of the Facility.                                                                                                                                                                                                                             |
| Risk Factors                                  |     | An investment in our common stock involves a high degree of risk and could result in a loss of your entire investment. Further, the issuance to, or sale by, the Selling Stockholder of a significant amount of shares being registered in the registration statement, of which this Prospectus forms a part, at any given time could cause the market price of our common stock to decline and to be highly volatile, and we do not have the right to control the timing and amount of any sales by the Selling Stockholder of such shares. Prior to making an investment decision, you should carefully consider all of the information in this Prospectus and, in particular, you should evaluate the risk factors set forth under the caption “Risk Factors” beginning on page 14. |
| Trading Symbol on the Nasdaq Capital Market   |     | LRHC                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

| (1) | Based on 1,223,918 shares                                                                     
 of common stock outstanding as of August 18, 2025 and excludes the following as of such date: |

| ● | 1,389 shares of our common stock issuable upon the exercise of warrants outstanding, at a weighted average exercise price of $796.75 per share; |

| ● | 54,155 shares of our common stock issuable upon the exercise of stock options outstanding, at a weighted average exercise price of $116.92 per share; |

| ● | 7,460 shares of our common stock issuable upon the vesting of restricted stock units; and |

| ● | 2,428 shares of our common stock reserved for future issuance under our Second Amended and Restated 
 2022 Equity Incentive Plan.                                                                         |

<div align='center'>13

RISK FACTORS</div>

The risks and uncertainties described therein and below could materially adversely affect our business, operating results and financial condition, as well as cause the value of our securities to decline. You may lose all or part of your investment as a result. You should also refer to the other information contained in this Prospectus, or incorporated by reference, including our financial statements and the notes to those statements, and the information set forth under the caption “Special Note Regarding Forward-Looking Statements.” Our actual results could differ materially from those anticipated in these forward-looking statements as a result